Bioimpacts. 2018;8(1): 59-75. doi: 10.15171/bi.2018.08
PMID: 29713603        PMCID: PMC5915710


Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective

Cited by CrossRef: 2

1- Safary A, Akbarzadeh Khiavi M, Mousavi R, Barar J, Rafi M. Enzyme replacement therapies: what is the best option?. Bioimpacts. 2018;8(3):153 [Crossref]
2- Noels H, Weber C, Koenen R. Chemokines as Therapeutic Targets in Cardiovascular Disease. ATVB. 2019; [Crossref]

BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.